TGen Clinical Research Services

Site:	TGen Clinical Research Services	Go to their website
Address:	10460 N. 92nd Street, Suite 206
City:	Scottsdale
State:	AZ
Zip:	85248
Country:	USA

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
1	A Phase I Open Label, Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study in SF1126, a PI Kinase (PI3K) Inhibitor, Given Twice Weekly by IV Infusion to Patients With Advanced or Metastatic Tumors	Ongoing, but not recruiting	Closed	SF1126	NCT00907205
1	A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable	Ongoing, but not recruiting	Closed	GDC-0941	NCT00876109
1	MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma	Terminated	Closed	MP470	NCT00504205
1	Phase I Trial of PX-478	Completed	Closed	PX-478	NCT00522652
1	Safety and Pharmacology of SNX-5422 Mesylate in Subjects With Refractory Solid Tumor Malignancies	Completed	Closed	SNX-5422	NCT00506805
1	Safety Study of PLX108-01 in Patients With Solid Tumors	Ongoing, but not recruiting	Closed	PLX3397 (PLX108-01)	NCT01004861
1	Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies	Ongoing, but not recruiting	Closed	MP470	NCT00894894